Minimally invasive trigeminal ablation in patients with refractory trigeminal neuralgia who are ineligible for intracranial intervention.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 13 04 2019
revised: 30 07 2019
accepted: 04 09 2019
pubmed: 21 9 2019
medline: 6 2 2020
entrez: 21 9 2019
Statut: ppublish

Résumé

We describe the use of minimally invasive trigeminal ablation, an endoscopic ablative technique to treat trigeminal neuralgia in patients who are traditionally poor surgical candidates. We present 4 patients who presented with refractory unilateral trigeminal neuralgia. Three of the patients had previously failed stereotactic radiosurgery and three of them have multiple sclerosis. Due either to lack of neurovascular compression, minimally invasive trigeminal ablation was offered. Intraoperatively, an incision is made along the buccal mucosa or mid-brow and the tissue is endoscopically dissected in a plane towards the symptomatic nerve. Once isolated, the epineurium is partially ablated with thermocautery and the tissue surrounding the nerve is decompressed. All patients reported resolution of their pain post-operatively and were pain free at last follow up. Two patients had mild hypesthesia over the ablated nerve territory. Minimally invasive trigeminal ablation is a safe and effective technique for symptomatic control of trigeminal neuralgia. The efficacy, low risk, and relative ease of the procedure makes it ideal for use in patients who are refractory to medical management and have no neurovascular compression, are unable to tolerate traditional surgery or have failed other therapies.

Identifiants

pubmed: 31537461
pii: S0967-5868(19)30715-5
doi: 10.1016/j.jocn.2019.09.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

42-46

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Yasser Tajali (Y)

Department of Neurology, Rutgers New Jersey Medical School, Newark, NJ, United States.

Max Ward (M)

Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, NJ, United States.

Mickey Abraham (M)

Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, NJ, United States.

Machteld Hillen (M)

Department of Neurology, Rutgers New Jersey Medical School, Newark, NJ, United States. Electronic address: machteld.hillen@rutgers.edu.

Omar Mahmoud (O)

Department of Radiation Oncology, Cancer Institute of New Jersey, Newark, NJ, United States.

Yehuda Herschman (Y)

Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, NJ, United States.

Antonios Mammis (A)

Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, NJ, United States.

Boris Paskhover (B)

Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, United States; Department of Facial Plastic Surgery, Rutgers New Jersey Medical School, Newark, NJ, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH